| Serial Number | 90309237 |
| Word Mark | RENBIO |
| Filing Date | Tuesday, November 10, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 28, 2025 |
| Registration Number | 7671681 |
| Registration Date | Tuesday, January 28, 2025 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 9, 2021 |
| Goods and Services | Chemical preparations for gene delivery pharmaceuticals for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals for the treatment of genetic or cell based conditions; Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Biological preparations for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical preparations for human use for the treatment and prevention of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical preparations for human and veterinary use, namely, antibiotics, antifungals and anti-virals |
| Goods and Services | Biological products, namely, DNA circle, DNA primers, linear DNA and buffers for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals; Biological products, namely, antibodies, multi-specific antibodies, antibody fragments, proteins, chimeric proteins, drug conjugates and enzymes, for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals |
| Goods and Services | Medical apparatus for the administration of biopharmaceuticals and vaccines, namely, drug delivery devices and systems being pulse and waveform generators for the delivery of sub-dermal or intramuscular or intravenous drugs; medical devices, namely, pulse and waveform generators for electroporation mediated administration of drugs to humans and animals; delivery systems comprised of pulse and waveform generators for the delivery of sub-dermal or intramuscular or intravenous drugs for administration of biopharmaceuticals and vaccines for the preventive or treatment of disease in humans and animals; handheld medical systems and devices comprised of pulse and waveform generators using electroporation for the prevention or treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders in humans and animals; handheld clinical delivery systems and devices comprised of pulse and waveform generators for the application of electrical fields in tissue, in particular muscle and skin, in conjunction with the administration of biopharmaceuticals |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 8, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | Thursday, November 7, 2024 |
| First Use In Commerce Date | Thursday, November 7, 2024 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 8, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, November 7, 2024 |
| First Use In Commerce Date | Thursday, November 7, 2024 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 8, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | Thursday, November 30, 2023 |
| First Use In Commerce Date | Thursday, November 30, 2023 |
| Party Name | RENBIO, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | LONG ISLAND CITY, NY 11101 |
| Party Name | RENBIO, INC. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | LONG ISLAND CITY, NY 11101 |
| Party Name | RenBio, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Long Island City, NY 11101 |
| Party Name | RenBio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Long Island City, NY 11101 |
| Event Date | Event Description |
| Friday, November 13, 2020 | NEW APPLICATION ENTERED |
| Friday, January 8, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 2, 2021 | ASSIGNED TO EXAMINER |
| Monday, April 5, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, April 5, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, September 9, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 5, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, September 9, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, September 9, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, October 5, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 5, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 6, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 7, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 20, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 9, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 9, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 4, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, May 19, 2022 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, July 1, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 1, 2022 | SOU EXTENSION 1 FILED |
| Friday, July 1, 2022 | SOU EXTENSION 1 GRANTED |
| Tuesday, July 5, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, January 3, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 3, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, January 3, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, January 5, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 20, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 20, 2023 | SOU EXTENSION 3 FILED |
| Tuesday, June 20, 2023 | SOU EXTENSION 3 GRANTED |
| Thursday, June 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 8, 2023 | SOU EXTENSION 4 FILED |
| Friday, December 8, 2023 | SOU EXTENSION 4 GRANTED |
| Thursday, June 20, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| Thursday, June 27, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, June 28, 2024 | DIVISIONAL PROCESSING COMPLETE |
| Friday, June 28, 2024 | DIVISIONAL REQUEST RECEIVED |
| Tuesday, July 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, December 8, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 12, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 2, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 2, 2024 | SOU EXTENSION 5 GRANTED |
| Tuesday, July 2, 2024 | SOU EXTENSION 5 FILED |
| Friday, September 13, 2024 | CORRECTED NOA E-MAILED |
| Wednesday, December 18, 2024 | USE AMENDMENT FILED |
| Wednesday, December 18, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Friday, January 3, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, January 7, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, January 8, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, January 8, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, January 28, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 28, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |